NRF2 as an Emerging Therapeutic Target

Affiliations

• ¹ MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool L69 3GE, UK.
• ² Division of Cancer Research, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.
• ³ Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
• ⁴ Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA.
• ⁵ Reata Pharmaceuticals Inc., 2801 Gateway Drive, Irving, TX 75063, USA.